AU2004290925B2 - Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients - Google Patents
Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients Download PDFInfo
- Publication number
- AU2004290925B2 AU2004290925B2 AU2004290925A AU2004290925A AU2004290925B2 AU 2004290925 B2 AU2004290925 B2 AU 2004290925B2 AU 2004290925 A AU2004290925 A AU 2004290925A AU 2004290925 A AU2004290925 A AU 2004290925A AU 2004290925 B2 AU2004290925 B2 AU 2004290925B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- treatment
- formula
- alkyl
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104264.1 | 2003-11-18 | ||
| EP03104264 | 2003-11-18 | ||
| PCT/EP2004/052963 WO2005049035A1 (en) | 2003-11-18 | 2004-11-15 | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2004290925A1 AU2004290925A1 (en) | 2005-06-02 |
| AU2004290925B2 true AU2004290925B2 (en) | 2010-07-01 |
Family
ID=34610099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004290925A Ceased AU2004290925B2 (en) | 2003-11-18 | 2004-11-15 | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
Country Status (15)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001036610A1 (en) * | 1999-11-19 | 2001-05-25 | Solvay Pharmaceuticals B.V. | Human enzymes of the metalloprotease family |
| PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| US20060159748A1 (en) * | 2004-12-23 | 2006-07-20 | Rajesh Jain | Oral immediate release formulation of a poorly water-soluble active substance |
| US11844803B2 (en) * | 2017-12-11 | 2023-12-19 | Aetas Pharma Co., Ltd. | Renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative |
| PL424453A1 (pl) * | 2018-01-31 | 2019-08-12 | Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością | Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) |
| ES2899200T3 (es) * | 2018-06-22 | 2022-03-10 | Synact Pharma Aps | Tratamiento de proteinuria |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0733642A1 (de) * | 1995-03-23 | 1996-09-25 | Kali-Chemie Pharma GmbH | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäure-derivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| WO2000048601A1 (de) * | 1999-02-16 | 2000-08-24 | Solvay Pharmaceuticals Gmbh | Arzneimittel zur behandlung von bluthochdruck |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0254032A3 (en) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| DE19638020A1 (de) * | 1996-09-18 | 1998-03-19 | Solvay Pharm Gmbh | Die gastrointestinale Durchblutung fördernde Arzneimittel |
| DE19932555A1 (de) * | 1999-07-13 | 2001-01-18 | Solvay Pharm Gmbh | Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen |
| SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| IL162645A0 (en) * | 2002-01-16 | 2005-11-20 | Solvay Pharm Bv | solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds |
| TW200306799A (en) * | 2002-05-17 | 2003-12-01 | Novartis Ag | Combination of organic compounds |
-
2004
- 2004-11-15 AR ARP040104208A patent/AR046454A1/es not_active Application Discontinuation
- 2004-11-15 CN CNB2004800330307A patent/CN100566719C/zh not_active Expired - Fee Related
- 2004-11-15 PL PL04818828T patent/PL1687006T3/pl unknown
- 2004-11-15 BR BRPI0416706-6A patent/BRPI0416706A/pt not_active IP Right Cessation
- 2004-11-15 JP JP2006540446A patent/JP4824573B2/ja not_active Expired - Fee Related
- 2004-11-15 AU AU2004290925A patent/AU2004290925B2/en not_active Ceased
- 2004-11-15 ES ES04818828T patent/ES2297536T3/es not_active Expired - Lifetime
- 2004-11-15 MX MXPA06005547A patent/MXPA06005547A/es active IP Right Grant
- 2004-11-15 DE DE602004010172T patent/DE602004010172T2/de not_active Expired - Lifetime
- 2004-11-15 TW TW093134862A patent/TWI344366B/zh not_active IP Right Cessation
- 2004-11-15 AT AT04818828T patent/ATE378053T1/de not_active IP Right Cessation
- 2004-11-15 EP EP04818828A patent/EP1687006B1/en not_active Expired - Lifetime
- 2004-11-15 CA CA002545802A patent/CA2545802A1/en not_active Abandoned
- 2004-11-15 WO PCT/EP2004/052963 patent/WO2005049035A1/en not_active Ceased
- 2004-11-16 US US10/988,847 patent/US7273860B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0733642A1 (de) * | 1995-03-23 | 1996-09-25 | Kali-Chemie Pharma GmbH | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäure-derivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| WO2000048601A1 (de) * | 1999-02-16 | 2000-08-24 | Solvay Pharmaceuticals Gmbh | Arzneimittel zur behandlung von bluthochdruck |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100566719C (zh) | 2009-12-09 |
| EP1687006B1 (en) | 2007-11-14 |
| CA2545802A1 (en) | 2005-06-02 |
| BRPI0416706A (pt) | 2007-01-16 |
| MXPA06005547A (es) | 2006-08-17 |
| US7273860B2 (en) | 2007-09-25 |
| DE602004010172T2 (de) | 2008-09-11 |
| AR046454A1 (es) | 2005-12-07 |
| TWI344366B (en) | 2011-07-01 |
| US20050137183A1 (en) | 2005-06-23 |
| AU2004290925A1 (en) | 2005-06-02 |
| ES2297536T3 (es) | 2008-05-01 |
| WO2005049035A1 (en) | 2005-06-02 |
| TW200526228A (en) | 2005-08-16 |
| PL1687006T3 (pl) | 2008-01-31 |
| ATE378053T1 (de) | 2007-11-15 |
| DE602004010172D1 (de) | 2007-12-27 |
| JP4824573B2 (ja) | 2011-11-30 |
| HK1097762A1 (zh) | 2007-07-06 |
| CN1878557A (zh) | 2006-12-13 |
| EP1687006A1 (en) | 2006-08-09 |
| JP2007511582A (ja) | 2007-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6693129B2 (en) | Compositions and methods for lowering plasma lipoprotein(A) and risk factors of cardiovascular diseases | |
| AU686706B2 (en) | Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds | |
| ES2200587T3 (es) | Combinaciones de inhibidors del transporte de acidos biliares del ileon e inhibidores de la proteina de transferencia de colesteril ester para indicaciones cardiovasculares. | |
| JP6437119B2 (ja) | 選択的s1p1レセプターアゴニストを含む薬学的合剤 | |
| AU2002211452A1 (en) | Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases | |
| JP2002533415A (ja) | 心臓血管に適用するための回腸胆汁酸輸送阻害剤およびニコチン酸誘導体の組み合わせ | |
| WO2002078625A2 (en) | Therapeutic combinations for cardiovascular and inflammatory indications | |
| JP2002533408A (ja) | 心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤およびニコチン酸誘導体の組み合わせ | |
| JP2002537258A (ja) | 高血圧の治療のための医薬 | |
| EP1687006B1 (en) | Pharmaceutical compositions for the treatment of renal dysfunction | |
| RU2423692C2 (ru) | Вещества для профилактики и лечения панкреатита | |
| JP2002220345A (ja) | 脂肪肝改善剤 | |
| HK1097762B (en) | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients | |
| JP5559696B2 (ja) | 糖尿病性腎症の治療剤 | |
| CA3034956C (en) | TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSE | |
| JPH0573728B2 (cg-RX-API-DMAC10.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |